38 filings
Page 2 of 2
8-K
0tuo jyhuuab147
12 May 16
Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2016
12:00am
8-K
4jadu
8 Mar 16
Nexvet Announces Successful Completion of NV-01 Pilot Field Study
12:00am
8-K
loyh8xgo
16 Feb 16
Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2016
12:00am
8-K
51a7jhju0 wkl
23 Nov 15
Regulation FD Disclosure
12:00am
8-K
y3hofm mg
20 Nov 15
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
s9exv338jyczh
16 Nov 15
Regulation FD Disclosure
12:00am
8-K
8o2u8ii2tbshb
5 Nov 15
Nexvet Reports Financial Results for First Quarter of Fiscal Year 2016
12:00am
8-K
onr61qxgzal1k otsz
17 Sep 15
Nexvet Secures Biomanufacturing Facility and Receives IDA Ireland Support
12:00am
8-K
nean7 k97
3 Sep 15
Nexvet Biopharma Reports Full Year Fiscal 2015 Results
12:00am
8-K
5blumj8yohg
2 Jul 15
Departure of Directors or Certain Officers
12:00am
8-K
is5ot2
8 Jun 15
Nexvet Advances Manufacturing Strategy
12:00am
8-K
vj9vy06jy68ux02vn
4 Jun 15
Nexvet Announces Positive Top-Line Results for Proof-of-Concept Efficacy Study of NV-02 in Cats with Degenerative Joint Disease
12:00am
8-K
8ik6k2w5x4bsaxu14ev
11 May 15
Nexvet Appoints Dr. Jürgen Horn as Chief Product Development Officer
12:00am
8-K
sidv 13m4sewko18
8 May 15
Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2015
12:00am
8-K
2bp5ada l79upm5k
16 Apr 15
Nexvet Provides Update on NV-01 Program
12:00am
8-K
x9z l7ty7q8563g2
1 Apr 15
Nexvet Biopharma Appoints Dr. George Gunn as Chairman
12:00am
8-K
vsz5wluav9jtsud rr
13 Mar 15
Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2015
12:00am
8-K
pd3ol4fv6yn 2k3a
9 Mar 15
Nexvet Provides Update on Pivotal Field Safety and Efficacy Study for NV-01
12:00am